CMAX Clinical Research is looking for people with mild asthma to participate in a clinical drug study
CMAX Clinical Research is trialling an inhaled investigational medication for people with asthma whose symptoms cannot be controlled by current therapies.
This trial has received ethics approval from the Bellberry Human Research Ethics Committee. The HREC Reference number is: 2018-05-354
To be eligible, participants* must be aged 18 to 55 and have a documents diagnosis of mild asthma. Participants must also have a Body Mass Index of 18 to 35.
*Females must be of non-childbearing potential: post-menopausal or surgically sterile
The study involves staying at CMAX for 12 nights and attending 2 follow up visits. The trial is located in Adelaide
Eligible participants will be paid for their time.
To register your interest or receive more information please phone CMAX on 1800 150 433.